These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15219124)

  • 1. [Infections of the lower respiratory tract of uncertain origin. Can a blood test prevent unnecessary antibiotic prescriptions? (interview by Dr. Judith Neumaier)].
    Müller B
    MMW Fortschr Med; 2004 Mar; 146(13):18. PubMed ID: 15219124
    [No Abstract]   [Full Text] [Related]  

  • 2. [Procalcitonin - a marker for managing antibiotic therapies?].
    Krawtchenko N; Franzen D; Müller B
    Praxis (Bern 1994); 2014 Feb; 103(4):187-93; quiz 194-5. PubMed ID: 24518234
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is procalcitonin determination for control of antibiotic therapy in acute respiratory infections of value?].
    Schütz P; Müller B; Briel M
    Praxis (Bern 1994); 2013 Mar; 102(7):413-4. PubMed ID: 23531909
    [No Abstract]   [Full Text] [Related]  

  • 4. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators.
    Christ-Crain M; Müller B
    Eur Respir J; 2007 Sep; 30(3):556-73. PubMed ID: 17766633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can procalcitonin testing reduce antibiotic prescribing for respiratory infections?
    Bignardi GE; Dhar R; Heycock R; Bansal S; Majmudar N
    Age Ageing; 2006 Nov; 35(6):625-6. PubMed ID: 16822805
    [No Abstract]   [Full Text] [Related]  

  • 6. [Procalcitonin as a biomarker in infections].
    Christ-Crain M
    Praxis (Bern 1994); 2007 Jun; 96(25-26):1017-21. PubMed ID: 17639964
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin-guided antibiotic therapy in COPD exacerbations: closer but not quite there.
    Martinez FJ; Curtis JL
    Chest; 2007 Jan; 131(1):1-2. PubMed ID: 17218546
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute infection of the lower respiratory tract: how long to observe?].
    Schmidt M
    MMW Fortschr Med; 2000 Nov; 142(48):37-41. PubMed ID: 11138286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the use of procalcitonin assay in hospitalized adult patients with pneumonia at a community acute care hospital.
    Kook JL; Chao SR; Le J; Robinson PA
    Infect Control Hosp Epidemiol; 2012 Apr; 33(4):424-6. PubMed ID: 22418643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin-guided antibiotic treatment in heart failure.
    Sandek A; Springer J; Habedank D; Brunkhorst F; Anker SD
    Lancet; 2004 May; 363(9420):1555; author reply 1555-6. PubMed ID: 15135615
    [No Abstract]   [Full Text] [Related]  

  • 12. Procalcitonin-guided antibiotic use in acute respiratory tract infections.
    Bollu M; Marte-Grau AC; Bobba RK
    Arch Intern Med; 2009 Apr; 169(7):716. PubMed ID: 19365003
    [No Abstract]   [Full Text] [Related]  

  • 13. Empiric antimicrobial therapy of community-acquired pneumonia: clinical diagnosis versus procalcitonin levels.
    Cunha BA
    Scand J Infect Dis; 2009; 41(10):782-4. PubMed ID: 19681019
    [No Abstract]   [Full Text] [Related]  

  • 14. Can procalcitonin levels guide antibiotic therapy in bacterial infections and reduce antibiotic overconsumption without having a negative effect on clinical outcomes?
    Sandifer JP; Jones AE
    Ann Emerg Med; 2012 Sep; 60(3):370-1. PubMed ID: 22305332
    [No Abstract]   [Full Text] [Related]  

  • 15. [Procalcitonin as a marker of severe bacterial infection in children].
    Schrøder H; Lodahl D
    Ugeskr Laeger; 2004 Oct; 166(43):3804-7. PubMed ID: 15544109
    [No Abstract]   [Full Text] [Related]  

  • 16. [Systemic markers of exacerbated chronic obstructive pulmonary disease: how they can help with the decision of whether or not to prescribe antibiotics].
    Soler N
    Arch Bronconeumol; 2008 Nov; 44(11):581-3. PubMed ID: 19007562
    [No Abstract]   [Full Text] [Related]  

  • 17. Procalcitonin in intensive care units: the PRORATA trial.
    Mokart D; Leone M
    Lancet; 2010 May; 375(9726):1605; author reply 1606-7. PubMed ID: 20452515
    [No Abstract]   [Full Text] [Related]  

  • 18. Procalcitonin in intensive care units: the PRORATA trial.
    Tarnow-Mordi W; Gebski V
    Lancet; 2010 May; 375(9726):1605; author reply 1606-7. PubMed ID: 20452513
    [No Abstract]   [Full Text] [Related]  

  • 19. Procalcitonin in intensive care units: the PRORATA trial.
    Gibot S
    Lancet; 2010 May; 375(9726):1605-6; author reply 1606-7. PubMed ID: 20452514
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum procalcitonin can guide antibiotic administration for respiratory tract infections in primary care.
    Mathioudakis AG; Chatzimavridou-Grigoriadou V; Evangelopoulou E; Mathioudakis GA
    BMJ; 2016 Aug; 354():i4245. PubMed ID: 27495796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.